Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Non Operating Income: 2012-2025

Historic Non Operating Income for Ani Pharmaceuticals (ANIP) over the last 14 years, with Sep 2025 value amounting to -$853,000.

  • Ani Pharmaceuticals' Non Operating Income rose 66.35% to -$853,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$294,000, marking a year-over-year increase of 89.06%. This contributed to the annual value of -$4.0 million for FY2024, which is 2436.48% down from last year.
  • Ani Pharmaceuticals' Non Operating Income amounted to -$853,000 in Q3 2025, which was down 149.05% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Non Operating Income peaked at $1.7 million during Q2 2025, and registered a low of -$2.7 million during Q4 2021.
  • For the 3-year period, Ani Pharmaceuticals' Non Operating Income averaged around -$282,545, with its median value being -$39,000 (2023).
  • Per our database at Business Quant, Ani Pharmaceuticals' Non Operating Income tumbled by 6,400.00% in 2024 and then skyrocketed by 2,076.14% in 2025.
  • Quarterly analysis of 5 years shows Ani Pharmaceuticals' Non Operating Income stood at -$2.7 million in 2021, then soared by 98.44% to -$42,000 in 2022, then rose by 21.43% to -$33,000 in 2023, then plummeted by 4,075.76% to -$1.4 million in 2024, then surged by 66.35% to -$853,000 in 2025.
  • Its Non Operating Income stands at -$853,000 for Q3 2025, versus $1.7 million for Q2 2025 and $198,000 for Q1 2025.